NCT04974177

Brief Summary

THIS IS A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE ROLE OF PHYSICIAN GESTALT IN CLINICAL PREDICTION OF COVID 19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
876

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

March 13, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

July 21, 2021

Last Update Submit

March 10, 2024

Conditions

All Patients Undergoing COVID 19 Specific Testing

Outcome Measures

Primary Outcomes (1)

  • Sensitivity, specificity, positive and negative likelihood ratio of physician gestalt in diagnosis of COVID 19 in patients presenting to ED who are being sent for COVID 19 specific testing.

    march 2021- september 2022

Secondary Outcomes (1)

  • Sensitivity, specificity, positive and negative likelihood ratio of clinical and epidemiological variables in patients presenting to ED who are being sent for COVID 19 specific testing.

    march 2021- september 2022

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients presenting to ED, who undergo COVID 19 specific testing.

You may qualify if:

  • All patients presenting to ED, who undergo COVID 19 specific testing.

You may not qualify if:

  • Patients with active COVID 19 disease diagnosed outside All brought dead cases. All patients not consenting to take part in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jubilee Mission Medical College

Thrissur, Kerala, 680005, India

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Junior Resident

Study Record Dates

First Submitted

July 21, 2021

First Posted

July 23, 2021

Study Start

March 15, 2021

Primary Completion

September 15, 2022

Study Completion

September 15, 2022

Last Updated

March 13, 2024

Record last verified: 2024-03

Locations

IN(1)